Stock Screener: Medical , Medical-Biomed-Genetics

The medical or healthcare sector comprises of those stocks which are involved in the production of medical goods.
Medical-Biomed-Genetics belongs to the sector Medical. This industry has a Market Cap of 721.87B. The top rated companies for Medical-Biomed-Genetics industry are: Amgen (AMGN) , Celgene (CELG) , Gilead Sciences (GILD).

Select Sector Select Industry
Click on the column to sort the table.
Company Stock Rating Market Cap PE Ratio 1W 52W
Amgen (AMGN)
4.4/5 127.62B 16.91 3.03% 17.57%
Anika Therapeutics (ANIK)
4.2/5 716.23M 22.88 -4.63% 26.15%
Gilead Sciences (GILD)
4.2/5 91.5B 6.97 2.58% -21.57%
Biogen Inc (BIIB)
4.1/5 62.4B 16.96 0.62% 10.78%
Regeneron Pharma (REGN)
4.0/5 39.15B 48.26 -1.3% -3.93%
Cambrex (CBM)
4.0/5 1.76B 22.23 4.27% 43.79%
China Biologic Products (CBPO)
4.0/5 2.98B 29.92 -3.58% -6.68%
PDL BioPharma (PDLI)
3.8/5 375.78M 2.09 -3.9% -25.5%
Celgene (CELG)
3.8/5 94.26B 48.16 2.07% 17.05%
Myriad Genetics (MYGN)
3.8/5 1.27B 22.99 12.04% -45.13%
Innoviva (INVA)
3.8/5 1.31B 22.67 -0.08% 3.24%
Enzo Biochem (ENZ)
3.8/5 316.62M 7.99 3.87% 57.51%
Emergent Biosolutions (EBS)
3.7/5 1.23B 30.28 -0.73% -19.13%
Illumina (ILMN)
3.7/5 23.9B 51.81 -1.4% 8.14%
Incyte (INCY)
3.7/5 22.82B 226.59 -0.78% 69.92%
AMAG Pharma (AMAG)
3.6/5 826.17M - 5.52% -6.49%
BioTechne Corporation (TECH)
3.6/5 3.93B 50.20 0.85% 21.79%
ANI Pharma (ANIP)
3.6/5 755.71M 91.38 -1.65% 83.66%
Alexion Pharma (ALXN)
3.6/5 28.93B 73.80 0.3% -8.57%
Integra LifeSciences (IART)
3.4/5 3.3B 57.10 1.59% 52.57%
Qiagen (QGEN)
3.4/5 6.67B 84.53 -1% 33.86%
Repligen (RGEN)
3.4/5 1.05B 152.40 0.43% 21%
Five Prime Therapeutics (FPRX)
3.3/5 1.38B 5.23 1.46% 43.65%
Horizon Pharma (HZNP)
3.3/5 2.74B - 2.44% -5.96%
Ligand Pharma (LGND)
3.3/5 2.21B 309.74 -1.6% 14.58%
Applied Genetic Technologies (AGTC)
3.2/5 146.48M 13.86 9.72% -45.7%
Heska (HSKA)
3.2/5 572.95M 65.92 -0.08% 153.15%
Osiris Therapeutics (OSIR) 3.1/5 207.41M 78.00 1.38% -20.35%
MiMedx (MDXG)
3.1/5 907.88M 46.72 2.44% 1.08%
NeoGenomics (NEO)
2.8/5 626.53M - -4.36% 34.58%
Exelixis (EXEL)
2.7/5 6.62B - 4.95% 495.62%
Cytokinetics (CYTK)
2.6/5 456.93M 34.67 -8.37% 55.92%
Retrophin (RTRX)
2.5/5 779.92M - -0.49% 40.76%
Acorda Therapeutics (ACOR)
2.5/5 1.17B - 6.08% -25.48%
Vertex Pharma (VRTX)
2.5/5 21.93B - -2.65% 1.49%
Seattle Genetics (SGEN)
2.5/5 9.27B - 4.45% 122.57%
Genomic Health (GHDX)
2.5/5 974.57M - 2.02% 10.56%
Alkermes (ALKS)
2.4/5 8.29B - -5.28% 58.91%
BioMarin Pharma (BMRN)
2.4/5 15.46B - -1.04% 19.35%
Vanda Pharmaceuticals (VNDA)
2.4/5 659.21M - -0.68% 88.56%
Lexicon Pharma (LXRX)
2.4/5 1.64B - 1.81% 74.83%
Amarin (AMRN)
2.3/5 947.53M - 2.64% 155.47%
Kamada (KMDA)
2.3/5 256.95M - -1.05% 93.04%
Halozyme Therapeutics (HALO)
2.3/5 1.63B - -0.71% 61.21%
Array BioPharma (ARRY)
2.2/5 1.92B - -9.33% 323.35%
EXACT Sciences (EXAS)
2.2/5 2.16B - 18.57% 249.61%
Momenta Pharma (MNTA)
2.2/5 1.35B - -15.75% 67.01%
Geron (GERN)
2.2/5 362.85M - -9.09% -16.98%
Organovo (ONVO)
2.2/5 310.1M - 0.67% 40.85%
Nymox Pharmaceutical (NYMX)
2.2/5 157.96M - 5.36% 46.89%
Galapagos (GLPG)
2.2/5 3.23B - 2.63% 70.58%
Keryx Biopharma (KERX)
2.2/5 536.16M - -9.76% 50.76%
Cellectis (CLLS)
2.2/5 781.97M - -0.13% 5.87%
Sinovac Biotech (SVA)
2.1/5 321.85M - 0.45% -12.11%
Aduro BioTech (ADRO)
2.1/5 792.75M - 4.42% -18%
Uniquire (QURE)
2.1/5 158.66M - -7.29% -59.03%
Coherus Biosciences (CHRS)
2.1/5 1.1B - -1.52% 62.84%
Regenxbio (RGNX)
2.1/5 458.1M - 3.54% 33.66%
Inovio Pharma (INO)
2.0/5 515.47M - -0.87% 5.59%
NewLink Genetics (NLNK)
2.0/5 444.89M - 1.92% -30.21%
VIVUS (VVUS)
2.0/5 114.28M - 0 4.76
Arna Pharma (ARNA)
2.0/5 362.67M - -0.68% -0.68%
Sorrento Therapeutics (SRNE)
2.0/5 282.4M - -7.89% -12.35%
Curis (CRIS)
2.0/5 376.67M - 1.14% 86.01%
Alnylam Pharma (ALNY)
1.9/5 4.15B - 1.63% -21.18%
The Medicines Company (MDCO)
1.9/5 3.78B - 3.51% 60.2%
Intellia Therapeutics (NTLA)
1.9/5 487.37M - -3.41% -39.77%
Evogene (EVGN)
1.9/5 135.3M - 2.63% -18.6%
Celldex Therapeutics (CLDX)
1.9/5 426.75M - -3.15% -49.48%
Intercept Pharma (ICPT)
1.9/5 3.19B - -1.19% 5.16%
Compugen (CGEN)
1.9/5 231.63M - -2.15% -5.6%
Immunomedics (IMMU)
1.8/5 566.47M - -1.36% 148.04%
Merrimack Pharma (MACK)
1.8/5 414.72M - -2.17% -40.71%
Spark Therapeutics (ONCE)
1.8/5 1.98B - -0.06% 100.96%
Arbutus Biopharma (ABUS)
1.8/5 148.07M - 1.89% -14.83%
Juno Therapeutics (JUNO)
1.8/5 2.45B - 2.46% -30.16%
Acceleron Pharma (XLRN)
1.8/5 1.01B - -0.53% 1.53%
Cellular Biomedicine (CBMG)
1.8/5 175.29M - 0 -30.79
Agenus (AGEN)
1.8/5 395.96M - 3.18% 60.99%
Editas (EDIT)
1.8/5 953.79M - 44.59% 20.56%
Kite Pharma (KITE)
1.8/5 2.73B - 0.86% 21.14%
Mesoblast (MESO)
1.8/5 514.98M - 6.39% 6.92%
Blueprint Medicines (BPMC)
1.7/5 1.15B - -1.46% 96%
Stemline Therapeutics (STML)
1.7/5 160.83M - 0 67.07
Idera Pharma (IDRA)
1.7/5 256.92M - 5.06% -4.6%
Cara Therapeutics (CARA)
1.7/5 402.7M - -5.34% 110.3%
Ophthotech (OPHT)
1.7/5 160.64M - -5.22% -90.39%
bluebird bio (BLUE)
1.7/5 3.13B - -3.85% 48.17%
Acadia Pharma (ACAD)
1.7/5 4.76B - -1.23% 104.27%
Adverum (ADVM)
1.7/5 116.81M - -5.17% -48.6%
CytomX Therapeutics (CTMX)
1.6/5 431M - 3.02% -5.99%
ZIOPHARM Oncology (ZIOP)
1.6/5 903.68M - 0.59% -6.19%
Abeona Therapeutics (ABEO)
1.6/5 239.76M - -4.55% 120.59%
Epizyme (EPZM)
1.6/5 742.54M - 2.07% 38.36%
Sangamo BioSciences (SGMO)
1.6/5 282.5M - -2.47% -25.47%
Dynavax Technologies (DVAX)
1.5/5 154.11M - -2.47% -78.12%
OncoMed Pharma (OMED)
1.5/5 323.81M - 3.6% -4.09%
Revance (RVNC)
1.5/5 597.39M - 0 14.38
Argos Therapeutics (ARGS)
1.5/5 193.94M - -6.38% -1.12%
Achillion Pharma (ACHN)
1.5/5 583.63M - -2.47% -35.07%
Prothena (PRTA)
1.5/5 1.9B - 5.69% 67.63%
Advaxis (ADXS)
1.5/5 367.52M - -0.99% 55.98%
Proteostasis (PTI)
1.5/5 407.1M - -2.45% 132.62%
Ascendis Pharma (ASND)
1.4/5 890.27M - 6.38% 42.85%
Reata Pharma (RETA)
1.4/5 207.28M - -0.26% 76.36%
Vtv Therapeutics (VTVT)
1.4/5 170.95M - -3.76% -11.66%
Adaptimmune Therapeutics (ADAP)
1.4/5 290.93M - 0.24% -44.95%
MyoKardia (MYOK)
1.4/5 400.72M - 1.24% 69.92%
NantKwest (NK)
1.4/5 430.82M - -6.57% -30.34%
MediciNova (MNOV)
1.4/5 210.97M - -1.47% 13.96%
Novavax (NVAX)
1.4/5 409.58M - 2.11% -69.98%
Sarepta Therapeutics (SRPT)
1.3/5 1.54B - 1.45% 102.69%
Xenon Pharma (XENE) 1.3/5 148.51M - 0 13.95
Insmed (INSM)
1.3/5 954.78M - -3.98% 19.41%
MannKind (MNKD)
1.3/5 251.76M - -6.25% -45.57%
Beigene (BGNE)
1.3/5 1.28B - 5.5% 46.22%
Alder BioPharma (ALDR)
1.3/5 1.17B - -6.65% 16.38%
Amicus Therapeutics (FOLD)
1.3/5 894.68M - -2.75% -13.53%
Paratek Pharma (PRTK)
1.3/5 364.31M - -4.05% 15.36%
Trevena (TRVN)
1.2/5 397.85M - -42.68% -51.37%
Intra-Cellular Therapies (ITCI)
1.1/5 574.17M - -4.26% -56.59%
Igene Biotechnology (IGNE) - 0.31M - 0 -100
ARYx Therapeutics (ARYX) - 0.23M - 16.67% 133.33%
Tengion (TNGNQ) - 0.05M - 0 0
Bionovo (BNVIQ) - 0.02M - 0 0
Protein Polymer (PPTIQ) - 0.06M - 0 0
Wowi (WOWU) - 11.12B - 0 370.59
Gliatech (GLIAQ) - 0M - N/A N/A
Cellcyte Genetics (CCYG) - 0.12M - 0 -33.33
Viralytics (VRACY) - 196.24M - 0 66.67
Cormedix (CRMD) - 91.77M - 3.7% 21.74%
Williston Holding (WHCA) - 3.93M - 0 900
Neuro Hitech (NHPI) - 0M - 0 0
Asterias Biotherapeutics (AST) - 172.74M - -1.35% 4.29%
IR Biosciences (IRBS) - 0M - 0 -100
Addex Therapeutics (ADDXF) - 24.89M - 0 -37.29
Biocoral (BCRA) - 1.23M - N/A N/A
BioTime (BTX) - 324.48M 15.14 9.28% 37.66%
Provectus Biopharma (PVCT) - 7M - -5% -95.94%
Regenicin (RGIN) - 18.42M - 51.52% 689.47%
Genitope (GTOPQ) - 0.06M - 0 0
ZYTO Corp (KAEN) - 1.08M - -18.42% 34.78%
Mast Therapeutics (MSTX) - 33.14M - -5.93% -53.48%
Deltagen (DGEN) - 0M - 0 -100
Helix Biomedix (HXBM) - 7.85M - 0 0.64
USA Equities Corp (USAQ) - 0.03M - 0 -96.67
Marina Biotech (MRNA) - 15.71M - -13.16% 17.86%
AtheroNova (AHROQ) - 0.09M - -10% -76.32%
Nanobac Pharma (NNBP) - 0.07M - 0 0
Introgen Therapeutics (INGNQ) - 0M - N/A N/A
Accentia BioPharma (ABPI) - 0.01M - N/A N/A
Bellus Health (BLUSF) - 11.85M - -1.02% -75.99%
Oncolytics Biotech (ONCYF) - 33.53M - 22.13% -0.35%
Protalix Biotherapeutics (PLX) - 107.92M - -15.2% 35.9%
Quick-Med Technologies (QMDT) - 1.72M - 50% 500%
Redpoint Bio (RPBC) - 0.08M - 0 0
Health Discovery (HDVY) - 2.99M - 0 -65.63
Respirerx Pharma (RSPI) - 7.27M - -1.27% -28.47%
NeurogesX (NGSX) - 0.17M - -37.5% -37.5%
HedgePath Pharma (HPPI) - 123.69M - -6.06% 210%
iBio (IBIO) - 35.64M - -2.5% -35%
Amarillo (AMAR) - 4.94M - -6.4% 80%
Myrexis (MYRX) - 2.07M - 25% -24.24%
Pfenex (PFNX) - 183.13M 25.07 -0.89% 0.26%
Interleukin Genetics (ILIU) - 22.94M - -8.33% 69.23%
Insite Vision (INSV) - 45.85M - N/A N/A
Synthetic Biologics (SYN) - 94.04M - -3.53% -48.84%
PROTAGENIC THER (PTIX) - 51.31M - 0 -64.07
Immune Therapeutics (IMUN) - 13.74M - -22.54% -68.57%
Biocurex (BOCX) - 0M - N/A N/A
Panacos Pharma (PANC) - 0.01M - -100 0
Response Genetics (RGDXQ) - 0.03M - -100% -100%
Genmab (GNMSF) - 12.04B 108.62 0.37% 71.46%
Cel-Sci Corporation (CVM) - 18.89M - -22.31% -83.17%
Nicox (NICXF) - 236.3M - 0 28.92
Nutra Pharma (NPHC) - 1.94M 1.29 28.57% -68.97%
Atara Bio (ATRA) - 450.23M - -1.27% 2.84%
ImmunoCellular Therapeutics (IMUC) - 9.41M - -8.78% -73.88%
International Stem Cell Corp (ISCO) - 4.09M - -5.61% -71.06%
Advanced Life Sciences (ADLS) - 0M - 0 -100
Theratechnologies (THERF) - 225.04M - 0.51% 159.57%
BioForce Nanosciences (BFNH) - 0.4M - -11.11% 60%
Capstone Therapeutics Corp. (CAPS) - 3.35M - -8.89% 9.33%
Pathfinder Cell (PFND) - 0.67M - 0 -75
Power 3 Medical (PWRM) - 0.06M - N/A N/A
Regenerx Biopharma (RGRX) - 32.57M - 3.45% -33.33%
Guangzhou Pharma (GZPHY) - 726.88M - 0 0
VG Life Sciences (VGLS) - 0.77M - 0 -47.62
Clovis Oncology (CLVS) - 2.92B - 0.62% 257.29%
Volitionrx (VNRX) - 115.59M - 1.38% 26.14%
DNAPrint Genomics (DNAG) - 0.06M - 0 0
Savient Pharma (SVNTQ) - 0.59M - N/A N/A
Taxus Cardium Pharma (CRXM) - 3.5M - -1.92% 27.5%
GeneLink (GNLKQ) - 0.37M - -100 0
Akesis Pharma (AKESQ) - 0.03M - N/A N/A
Arbutus Biopharma (ABUS)
- 148.07M - 1.89% -14.83%
Actelion (ALIOF) - 28.88B - 0.44% 100.36%
Prodite Pharma (PPMD) - 0.12M - 0 -25
Ampliphi Biosciences (APHB) - 8.74M - -1.54% -84.55%